comunicacio

Fifty years of Bellvitge data reveal how pneumococcus, antibiotic resistance and meningitis have evolved

Epidemiology of  bacterial infections, pathogenesis and molecular basis of antimicrobial resistance , Infectious disease and transplantation Program, Translational Medicine Area / By

A study of 387 patients, published in The Lancet Microbe, shows major differences in outcomes depending on the route of the infection

Fifty years of Bellvitge data reveal how pneumococcus, antibiotic resistance and meningitis have evolved Read More »

Patients and researchers join forces to advance DICER1 syndrome research in Europe

Cancer, Cross-disciplinary Program in Adult Rare Diseases, Hereditary cancer , Molecular Mechanisms and Experimental Therapy in Oncology Program - Oncobell / By

The initiative aims to support families, establish a European patient registry, and accelerate research into an extremely rare condition

Patients and researchers join forces to advance DICER1 syndrome research in Europe Read More »

“Thanks to REMMA Bellvitge’s research, my children will be spared years of fear and invasive tests” (Maira, patient with Familial Adenomatous Polyposis)

Cancer, Cross-disciplinary Program in Adult Rare Diseases, Hereditary cancer , Molecular Mechanisms and Experimental Therapy in Oncology Program - Oncobell / By

Identifying the exact cause of a rare inherited disease can change the future of entire generations

“Thanks to REMMA Bellvitge’s research, my children will be spared years of fear and invasive tests” (Maira, patient with Familial Adenomatous Polyposis) Read More »

A genetic discovery at Bellvitge enables a family to anticipate hereditary cancer after years without answers

Cancer, Cross-disciplinary Program in Adult Rare Diseases, Hereditary cancer , Molecular Mechanisms and Experimental Therapy in Oncology Program - Oncobell / By

New genetic research strategies increase the ability to identify underlying genetic cause of rare syndromes

A genetic discovery at Bellvitge enables a family to anticipate hereditary cancer after years without answers Read More »

Epigenetic modification could open a new avenue to combat acute myeloid leukaemia

Cancer, Hematopoyetic and lymphoid tumors , Molecular Mechanisms and Experimental Therapy in Oncology Program - Oncobell, Regenerative Medicine Area, Regenerative Medicine Program, Stem Cell Aging / By

An IDIBELL study shows that increasing the methylation of a histone reduces the proliferation capacity of leukaemia cells

Epigenetic modification could open a new avenue to combat acute myeloid leukaemia Read More »

Scroll to Top